People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GT Metabolic Solutions Inc | — | Other | Series B | $46.5M | $168.7M | 2022 |
| EndoMetabolic Solutions, Inc. | — | Biotechnology | Seed | $3.8M | $169.9M | 2009 |
Michel Gagner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michel Gagner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter McNerney | 1 | 6 |
| Thierry Thaure | 1 | 5 |
| Dale A. Spencer | 1 | 2 |
| Kathy Tune | 1 | 1 |
| David J. Blaeser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.